5 Diagnostic reagents for medical use in the field of cancer; diagnostic reagents for clinical or medical laboratory use, namely, for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; diagnostic reagents for detection of gene mutation for clinical, oncology, and hematology diagnostics; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily of reagents, slides, solid matrix materials, microfluidic devices sold as a unit; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit; medical diagnostic reagents for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; reagents for microfluidic instruments for medical use; kits for research use, diagnostics use and drug development, namely, oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores; kits for research use, diagnostics use and drug development, namely, oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores